30.8 C
Vientiane
Monday, September 8, 2025
spot_img
Home Blog

Taskforce Launches Fundraising Campaign to Combat COVID-19

The Lao Government has opened a donation channel for all those looking to contribute financially to the fight against the outbreak of COVID-19.

Solar power project transforms desert into energy hub


ORDOS, CHINA – Media OutReach Newswire – 8 September 2025 – From September 16 to 17, 2025, the 10th Kubuqi International Desert Forum will convene in Ordos, Inner Mongolia Autonomous Region. Recently, reporters visited the Kubuqi Desert to investigate desertification control measures.

image-1.jpeg

Seen from the air, 196,000 solar panels stretch across the Kubuqi Desert in a striking horse-shaped mosaic, while on the ground, visitors to Chaideng Village, Ordos City, stroll along the solar station and nearby farmstays, savouring local delicacies in what was once the desolate “sea of death.”

The Kubuqi Desert, China’s seventh-largest, located in Inner Mongolia Autonomous Region, was once known as the “sea of death.” However, it boasts abundant solar resources and is an ideal place to build a solar power station.

An aerial drone photo taken on Sept. 3, 2025 shows a photovoltaic and desertification control project in Kubuqi Desert, north China's Inner Mongolia Autonomous Region.
An aerial drone photo taken on Sept. 3, 2025 shows a photovoltaic and desertification control project in Kubuqi Desert, north China’s Inner Mongolia Autonomous Region.

The Junma solar power station — “Junma” meaning “fine horse” in Chinese — is part of an ambitious desert reclamation project known as the “great photovoltaic wall,” stretching along the northern edge of the Kubuqi Desert.

The grand project is planned to extend about 400 kilometers with an average width of five kilometers. Upon completion, it is set to have an installed capacity of 100 million kilowatts.

At the Kubuqi Desert Ordos Central-Northern New Energy Base project, located in the central section of the “great photovoltaic wall,” rows of blue solar panels glisten under the sun.

“The first and second phases of the project, each with an installed capacity of one gigawatt, have been successfully connected to the grid, transforming over 63,000 mu (about 4,200 hectares) of desert into a sea of solar panels,” said Na Guiting, deputy president of Inner Mongolia Three Gorges Mengneng Energy Co., Ltd., the company responsible for the project.

As one of China’s first large-scale renewable energy bases with a capacity exceeding 10 gigawatts, the base is set to develop eight gigawatts of solar power, four gigawatts of wind power, and four gigawatts of supporting coal power.

Once the project is completed, it will deliver approximately 40 billion kilowatt-hours of electricity annually to the Beijing-Tianjin-Hebei region, with over 50 percent coming from clean energy sources, according to Na.

It is equivalent to saving about 6 million tonnes of standard coal and reducing carbon dioxide emissions by around 16 million tonnes each year, Na added.

Beneath the solar panels, various sand-fixing plants are thriving.

The panels provide shade, cut groundwater evaporation and reduce wind speeds, all of which support plant growth, said Hong Guangyu, a researcher with the Academy of Forestry Sciences of Inner Mongolia Autonomous Region, adding that the plants prevent dust from rising, which in turn benefits solar power generation.

The city of Ordos, also known for its abundant coal resources, has several large coal mines around the Kubuqi Desert. The treated drainage water from the coal mines is channeled to the solar power base and used to clean the solar panels and water the plants.

Local residents are also reaping the benefits of the solar projects. “These projects shield us from wind and sand, allowing our village to cultivate over 10,000 mu of high-standard farmland this year. If leased out, the land can bring villagers 900 yuan (about 126.6 U.S. dollars) per mu each year,” said Han Rongkuan, a local farmer.

At the 16th Conference of the Parties to the United Nations Convention to Combat Desertification, Ordos shared its experience in photovoltaic-based desertification control with other cities.

“The story of solar power projects in Kubuqi Desert embodies Chinese wisdom and solutions, demonstrating a sustainable path that combines ecological and economic benefits in the fight against desertification,” Hong said.

Under China’s Three-North Shelterbelt Forest Program (TSFP), the world’s largest afforestation initiative launched in 1978 to combat desertification across the country’s northwestern, northern and northeastern regions, a total of 480 million mu of forests have been planted and preserved, while 1.28 billion mu of degraded grasslands have been successfully restored.

At the Central Economic Work Conference in 2024, China urged efforts to push for major progress in the landmark projects of the TSFP and promote faster construction of new energy bases in sandy areas, rocky areas and deserts.

The issuer is solely responsible for the content of this announcement.

ONYX Hospitality Group Spotlights Shama Serviced Apartments: Redefining Urban Living Across Asia


BANGKOK, THAILAND – Media OutReach Newswire – 8 September 2025 – As urban professionals increasingly turn to serviced apartments for a better balance of work, family, and lifestyle, ONYX Hospitality Group is spotlighting its Shama brand — a growing collection of residences in Thailand, Malaysia, Hong Kong, and China. Designed to meet the needs of today’s new generation of city dwellers, Shama offers the flexibility, convenience, and community that redefine the modern urban home.

Shama LS3

Shama: A New Way of Living

Shama is designed for executives, professionals, and families who require both short- and long-term accommodation. It offers spacious residences with functional layouts – complete with kitchens and living areas – alongside amenities for everyday life. All of this is complemented by hotel-standard services to ensure comfort and ease.

More than just providing a place to live, Shama reimagines the home experience by blending the warmth of home with the conveniences of a hotel. This approach resonates with modern city dwellers who value quality of life and flexibility over traditional property ownership. It is why Shama stands as a pioneer of the New Urban Living Mindset, making the idea of a “second home” a reality for today’s urbanites.

Shama is more than just a place to stay; it is a new way of living. Offering flexibility, convenience, and a better quality of life, Shama is redefining the modern home for city dwellers across Asia.

Why Serviced Apartments?

For the new generation, a home is more than just a house or a condominium. It is about quality of life, convenience, and a sense of community. Today’s urban dwellers, especially executives and office professionals, are seeking a place that genuinely enhances their lives. They want more than simply a bed for the night or a permanent suburban address; they aspire to a space that seamlessly balances work, relaxation, and family life.

For professionals advancing their careers, a home close to their workplace, with convenient transport links and comprehensive services, is a critical advantage. It enables them to focus fully on their work, safe in the knowledge that when they return, they can unwind and recharge both physically and mentally without worrying about everyday details. For parents with children studying in the city, a “home” means a safe and accessible environment with services and communities that ensure a high quality of life – an environment where their children can thrive.

The Serviced Apartment Advantage

Serviced apartments have therefore emerged as the ideal solution for modern city living. They present a superior alternative to renting a condominium, which can often mean limited space and few services, or staying in a hotel, which is rarely practical for longer-term stays. Unlike purchasing a home, which carries the burden of maintenance and the challenge of relocating as circumstances change, serviced apartments provide a flexible, convenient option.

With features perfectly suited to the urban lifestyle, serviced apartments provide spacious living areas complete with fully equipped kitchens, living rooms, and dedicated workspaces, as well as shared spaces for unwinding. Hotel-standard services take care of everyday essentials, while prime locations close to business districts, schools, and leading hospitals offer both convenience and peace of mind. Above all, serviced apartments foster a sense of community that enhances overall quality of life. And when the time comes to move on, residents can do so with ease – free from the burden of resale or letting.

This is why serviced apartments are becoming the new “second home” for today’s urban professionals. More than simply meeting residential needs, they combine flexibility, convenience, and quality of life for a truly fulfilling lifestyle.

Discover Shama across a range of locations, each designed to suit different lifestyles:

  • Shama Yen-Akat Bangkok
    A tranquil retreat in the Silom-Sathorn business district, surrounded by shops and restaurants. Ideal for pet owners and fitness enthusiasts, with Lumpini Park just minutes away.
  • Shama Ekamai Bangkok
    Situated in the vibrant Ekkamai-Thonglor area, surrounded by community malls, cafés, and restaurants. With spacious residences perfect for long stays, it offers convenient access to Bangkok’s key business districts.
  • Shama Lakeview Asoke Bangkok
    In the heart of Asoke, overlooking Benjakitti Park and close to major shopping, dining, and entertainment venues.
  • Shama Petchburi 47 Bangkok
    Nestled in a quiet yet central location adjacent to Bangkok Hospital, and close to wellness centres, spas, and leisure facilities, making it ideal for extended stays.
  • Shama Sukhumvit Bangkok
    A unique blend of greenery and modern conveniences in central Sukhumvit, with spacious residences and family-friendly amenities, just minutes from Bumrungrad Hospital.
  • Shama Rayong (Opening 2027)
    Ideally positioned for both business and family living, close to industrial estates and international schools, offering an ideal long-term stay option in one of Thailand’s most important economic hubs.

For more information about ONYX Hospitality Group, please visit www.onyx-hospitality.com. To learn more about Shama, visit www.shama.com

Hashtag: #ONYX

The issuer is solely responsible for the content of this announcement.

FDA Accepts Letter of Intent to Qualify LSM by VCTE (FibroScan®) as First Non-Invasive Surrogate Endpoint in MASH Clinical Trials

This milestone opens a path for FibroScan® to ultimately replace liver biopsy for patient enrollment and treatment response assessment in MASH drug development

WESTBOROUGH, Mass., Sept. 8, 2025 /PRNewswire/ — Echosens, the leader in non-invasive liver diagnostics, is announcing today that the U.S. Food and Drug Administration’s (FDA’s) Center for Drug Evaluation and Research (CDER), Office of New Drugs has accepted the company’s Letter of Intent for the qualification of Liver Stiffness Measurement by Vibration-Controlled Transient Elastography (FibroScan®) as a reasonably likely surrogate endpoint in clinical trials for metabolic dysfunction-associated steatohepatitis (MASH).

This is the first time the FDA is accepting the initiation of the qualification process of a non-invasive test as a reasonably likely surrogate endpoint in drug development for MASH—a progressive, advanced form of steatotic liver disease that can lead to cirrhosis, liver cancer, transplantation, or death. In a communication issued by the FDA, Frank Anania, MD, director of the Division of Hepatology and Nutrition in CDER, stated, “This proposal represents an important step toward adopting non-invasive tests in drug development for MASH.”

As stated in the Letter of Intent, LSM by VCTE (FibroScan®) can predict the risk of all-cause mortality or liver-related events in patients with MASH. Acceptance of the Letter of Intent opens a path for FibroScan® to ultimately replace liver biopsy as the primary endpoint for the interim analysis of trials designed for the accelerated approval of drugs for adults with non-cirrhotic MASH.

Replacing repeated liver biopsies, which are currently used to enroll patients and monitor therapeutic response, with FibroScan® would ease a significant burden on patients. A FibroScan® exam takes just a few minutes, is painless, and assesses the liver comprehensively, providing a full picture of liver health that can be repeated as often as needed.

Arun Sanyal, MD, Professor and Director at the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, School of Medicine Internal Medicine, Virginia Commonwealth University, said, “The acceptance of this Letter of Intent is a major milestone, built on years of clinical research and publications, together with the tireless efforts of numerous stakeholders across the field, with major implications for the field and is expected to accelerate drug development and also be easily translatable to clinical practice.”

This unprecedented acceptance of the Letter of Intent by the FDA is driven by FibroScan’s unmatched clinical validation and its use in key pharmaceutical trials in liver drug development, especially for MASH. Recognized worldwide as the leading non-invasive solution for liver health, FibroScan® is supported by more than 5,600 peer-reviewed publications, including pivotal publications (Gawrieh et al., Journal of Hepatology, 2024, Lin et al., JAMA, 2024, and Mózes et al., Lancet Gastroenterol Hepatol, 2023), showing that changes in LSM by VCTE are associated with liver-related outcomes. Furthermore, FibroScan® is already the reference point-of-care non-invasive test by all key pharma companies and biotechs conducting MASH trials. Echosens’ submission to the FDA included official letters of support from Eli Lilly, Boehringer Ingelheim, and Novo Nordisk.

For pharmaceutical companies, the acceptance of FibroScan® as a reasonably likely surrogate endpoint would have the potential to transform drug development in MASH by improving trial recruitment and patient retention. This milestone could accelerate the path to new therapies while helping researchers design safer and more representative, efficient trials. Professor Quentin Anstee, Pro-Vice-Chancellor, Faculty of Medical Sciences at Newcastle University, stated, “The FDA accepting this letter of intent is a critical first step to ultimately have non-invasive tests adopted as reasonably likely surrogate endpoints in MASH clinical trials. It’s a clear signal to all pharma sponsors to collect robust non-invasive biomarker data in their ongoing or future clinical trials in MASH.”

In addition to existing recommendations for FibroScan® from all prominent guidelines and its preferred position in payer policies, the acceptance of this Letter of Intent by the FDA further strengthens the position of FibroScan® as the reference non-invasive test to prescribe and monitor MASH treatments—both those already approved and those to come. This milestone also underscores the leadership and ongoing innovation of Echosens, which recently advanced its technology with Guided VCTE in the latest generation of FibroScan® devices—delivering greater efficiency, automation, and standardization to make liver scanning seamless for all healthcare providers.

About Echosens 
Pioneer in its field, Echosens, significantly changed the practice of liver assessment with FibroScan®, the non-invasive solution for comprehensive management of liver health. FibroScan® is recognized worldwide and validated by more than 5,600 peer-reviewed publications, including nearly 220 international guidelines. Echosens has made FibroScan® available in over 127 countries, enabling millions of liver examinations worldwide. https://www.echosens.com/

 

KuCoin Pay Partners with King Gift to Bridge Crypto to Everyday Shopping for Gaming, Entertainment, and Retail Gift Cards

PROVIDENCIALES, Turks and Caicos Islands, Sept. 8, 2025 /PRNewswire/ — KuCoin, a leading global cryptocurrency exchange, today announced that its crypto payment arm, KuCoin Pay, has established a strategic partnership with King Gift, a premier online platform specializing in digital gift cards. This collaboration integrates KuCoin Pay as a supported payment method on King Gift, empowering users to seamlessly purchase gift cards using popular cryptocurrencies.


Through this integration, KuCoin Pay facilitates secure and convenient transactions for a diverse range of digital gift cards across gaming, entertainment, retail, and more. By connecting cryptocurrency to everyday spending, the partnership highlights KuCoin’s dedication to promoting real-world applications of digital assets, making it simpler for users around the globe to integrate crypto into their daily routines.

“This partnership with King Gift represents a step forward in our mission to make cryptocurrency more practical and inclusive,” said Kumiko Ho, Head of Payment Business at KuCoin. “We’re committed to removing barriers and broadening access, enabling anyone—regardless of their location or expertise—to leverage their crypto holdings for real, tangible benefits like instant gift card purchases.”

“Partnering with KuCoin Pay allows us to provide our users with greater flexibility and convenience when purchasing gift cards,” said Bilal Khwaja, CEO at King Gift. “By embracing cryptocurrency payments, we’re making digital shopping simpler, faster, and more accessible for customers around the world.”

King Gift’s platform, renowned for its instant delivery and worldwide accessibility, complements KuCoin Pay’s focus on efficient crypto payments. Users can now experience flexible shopping with secure, cross-border transactions, driving greater adoption of digital currencies in everyday commerce. This partnership also offers unlimited 2% cashback on all purchases made via KuCoin Pay at King Gift until September 17, 2025.

About KuCoin Pay

KuCoin Pay is a pioneering merchant payment solution that enables businesses to integrate cryptocurrency transactions for both online and offline sales. Supporting over 50 cryptocurrencies including KCS, USDT, USDC, and BTC, KuCoin Pay delivers fast, secure, and borderless payments to a global audience.

Learn more about KuCoin Pay: https://www.kucoin.com/pay 

About King Gift

King Gift is a trusted online platform offering a wide range of digital gift cards for gaming, entertainment, retail, and more. With instant delivery and secure transactions, we make it simple for customers worldwide to access both global and regional gift cards. At King Gift, speed and convenience are at the heart of our service, supported by multiple payment options including leading cryptocurrency gateways for a smooth checkout experience.

King Gift’s mission is to make purchasing gift cards with crypto fast, reliable, and accessible from anywhere. Through strong partnerships and a focus on security, King Gift has become the go-to choice for users who value flexibility, global reach, and seamless digital shopping.

Learn More About King Gift: https://kingiftcard.com

Bybit Resumes Full Access for Indian Users, Reinforces Commitment to Compliance and Crypto Inclusion

DUBAI, UAE, Sept. 8, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, has restored full access to its Bybit app on the App Store and Google Play for users in India, making a crucial milestone in its long-term dedication to the Indian market. Meanwhile, access to the Bybit website is being restored in phases and is expected to be fully available within the next 3–4 days. This is after a wider effort in regulatory harmonization and a reflection of Bybit’s dedication to trust, transparency, and security for its increasing number of Indian users.

Bybit initiated the process of regulation in the initial months of the year by becoming registered with the Financial Intelligence Unit-India (FIU-IND) as a reporting entity in January 2025. This ensured that its activities are in full accordance with India’s Prevention of Money Laundering Act (PMLA). Through this, Bybit has reopened providing a range of services such as Spot, Derivatives, Options, and Copy Trading to Indian customers with solid Know Your Customer (KYC) procedures and improved security measures.

Operations were initially re-established on February 25, 2025, where authorized users could access all trading functionality. Complete functionality of the website and app was, however, brought live only after extensive interaction with authorities, which is now successfully achieved.

Commenting on the announcement, Ben Zhou, Co-founder and CEO of Bybit, said: “India is among the most promising digital asset markets globally. We are excited to resume normal business and reaffirm our devotion to delivering Indian users with secure, transparent, and world-class cryptocurrency experiences. It’s not a comeback, it’s a new chapter for Bybit in India.”

Vikas Gupta, Country Manager of Bybit India, added, “this is a milestone moment for Bybit India. We are thrilled to provide Indian users with a smooth and compliant trading experience. Our vision is not limited to trading. We are committed to building India’s rapidly expanding crypto ecosystem through mass education, strategic partnerships, and community-led initiatives.”

As part of its expanded footprint, Bybit became the Title Sponsor of the India Blockchain Tour 2025, which kicked off in Hyderabad on June 28. The next stop will be Metamorphosis – India Blockchain Tour, New Delhi, scheduled for September 27–28. Further strengthening its presence, Bybit has also launched the World Series of Trading (WSOT) 2025, featuring multiple campaigns that offer welcome bonuses for new users along with exciting rewards, including cars, iPhones, and more.

#Bybit / #TheCryptoArk  /#IMakeIt

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 70 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press

For media inquiries, please contact: media@bybit.com

For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

 

Discover Qianhai’s Talent Appeal from a “72-Hour Experience Pass”


SHENZHEN, CHINA – Media OutReach Newswire – 8 September 2025 – Recently, a “Shenzhen-Hong Kong 72-Hour Experience Pass” has drawn the attention of young “makers” from around the world. The experience program, jointly launched by the Authority of Qianhai Shenzhen-Hong Kong Modern Service Industry Cooperation Zone and the government of the Hong Kong Special Administrative Region, invites global experts to visit, experience, inspect, and collaborate in the Guangdong-Hong Kong-Macao Greater Bay Area. To support this, the program offers 500 air tickets, 200 seaside rooms, and 1,000 opportunities for high-paying jobs.

Shenzhen-Hong Kong 72-Hour Experience Pass
Shenzhen-Hong Kong 72-Hour Experience Pass

“This is not just a pass, but also a dialogue, a window, and the starting point of a career,” said an official from the Qianhai Authority. The Authority hopes that this precise, efficient, immersive, and interactive approach can break down information barriers, enabling talented people from around the world to realize their dreams in the Greater Bay Area, a land full of opportunities.

Shenzhen-Hong Kong 72-Hour Experience Pass
Shenzhen-Hong Kong 72-Hour Experience Pass

It is learned that the Shenzhen and Hong Kong governments will arrange customized itineraries based on applicants’ backgrounds and needs and provide comprehensive support. This includes assistance with obtaining Shenzhen entry visas, guidance and services throughout the trip, and subsidies covering accommodation, transportation, and meals. Global elites can access the application form by just scanning the official QR code and complete the application by submitting it to the email address designated by Qianhai or Hong Kong.

During the 72-hour trip, experts selected in the experience program will enjoy an immersive tour in Shenzhen and Hong Kong from three key perspectives: career, lifestyle, and opportunities. Activities include visits to top universities, sci-tech innovation parks, and world-class technology companies in Shenzhen and Hong Kong, as well as strolling on the shores of Victoria Harbor and riding the “Bay Glory” Ferris wheel.

This experience pass program, jointly launched by Shenzhen and Hong Kong, is a vivid example of the two regions working together to build a more internationally competitive talent system. In recent years, Qianhai and Hong Kong have enhanced “hard connectivity” by improving the interconnectivity in transportation, communications, and other infrastructure. In terms of “soft connectivity,” they have focused on advancing the alignment of rules and coordination of mechanisms, removing institutional barriers such as cross-border public services and mutual recognition of professional qualifications. These efforts aim to create a “seamless” development environment for more talented individuals and enterprises seeking opportunities in Qianhai.

The effort to attract global talent to the Greater Bay Area and encourage them to stay in Shenzhen and Hong Kong is underpinned by an increasingly comprehensive public service system and a business environment aligned with international standards jointly developed by Hong Kong and Qianhai. For example, the “Shenzhen Qianhai International Business e-Station” platform built by Qianhai provides integrated online and offline services, enabling “one-counter handling” of high-frequency matters such as cross-border notarization and talent introduction. It has become a key service hub for enterprises expanding overseas and for talent entering the Greater Bay Area.

Today, Qianhai has become a pivot for connecting resources across the Guangdong-Hong Kong-Macao Greater Bay Area and a strategic platform for integration with the international community. Through innovation and opening up, it is writing a new chapter in Shenzhen-Hong Kong collaboration. By offering growth opportunities for young people from Hong Kong and Macao, creating development prospects for talented people from around the world, and building bridges for enterprises seeking global expansion, Qianhai demonstrates its unique value and boundless potential as a strategic platform for Shenzhen-Hong Kong cooperation.

From the 72-hour experience pass to continuous empowerment from a comprehensive service system, Qianhai is conveying strong confidence and sincerity to global makers through its systematic and efficient service philosophy and actions. Here, there are not only vast development opportunities and the “key” to the Chinese mainland market, but also efficient and convenient service support, a more internationally aligned business environment, and a rainforest-like innovation ecosystem. Qianhai’s appeal is prompting global experts to “vote with their feet,” choosing to stay here and join the wave of innovation in the Guangdong-Hong Kong-Macao Greater Bay Area.

Hashtag: #72HourExperiencePass

The issuer is solely responsible for the content of this announcement.

Remplir™ Study Delivers Compelling 81% Success Rate

Data to support US sales roll out and EU + UK regulatory submissions 

  • Interim results from a new Remplir™ study demonstrated a compelling overall treatment success rate of 81.1% following nerve repair procedures.
  • Real World Evidence (RWE) patient data collected in the study confirms Orthocell’s nerve repair product, Remplir, as the ideal medical device for connecting severed nerves, protecting damaged nerves, or capping nerve ends after amputation.
  • The data demonstrated:
    • 83.9% of muscles innervated by repaired nerves achieved functional motor recovery.
    • 89.5% of nerve decompression procedures resulted in significant improvement or complete relief of symptoms.
    • No post-treatment complications or adverse reactions to Remplir were reported in any patient.
    • Results consistent with previously published clinical trial outcomes.
  • The data confirms the superior and predictable outcomes that Remplir delivers and is testament to why over 200 surgeons across more than 165 hospitals (and growing) are now using the product.
  • Study data will be an important addition to Orthocell’s medical education efforts in US sales roll out and provide supporting evidence for the EU + UK regulatory submission expected in Q4 CY25.
  • Orthocell ultimately targeting a Total Addressable Market (“TAM”) in selected jurisdictions in excess of US$3.5 billion[1].
  • Internal resources remain focused on the Remplir rollout in the US$1.6 Billion U.S. market[2], with in-country representatives making significant progress working with distributors to gain hospital approvals, on-board surgeons and establish active accounts. Initial US surgical cases continue to build.

PERTH, Australia, Sept. 8, 2025 /PRNewswire/ — Regenerative medicine company Orthocell Limited (ASX:OCC, “Orthocell” or the “Company”) is pleased to announce interim results from a new Remplir multi-centre post-market clinical follow-up study (“Remplir Real World Evidence study” or “Remplir RWE Study”). The overall treatment success rate for all procedure types included in the study was a compelling 81.1%. The Remplir RWE Study will be used by Orthocell to support US Remplir sales roll out and the regulatory submissions in the UK and EU, which is expected to be submitted late Q4 CY25.

This interim analysis demonstrates the utility of Remplir in surgical procedures for a range of peripheral nerve conditions, including restoration of hand function after cervical spinal cord or brachial plexus injury, and relief of symptoms in chronic nerve injuries such as carpal tunnel syndrome. Importantly, the results are consistent with the compelling clinical trial outcomes previously published in the Journal of Reconstructive Microsurgery Open.  

The Remplir RWE study is designed to collect and analyse treatment outcomes generated during the routine clinical practice of nerve repair procedures. RWE is an increasingly valuable contributor to regulatory decision-making, as it provides evidence of product safety and performance from everyday clinical settings, in contrast to the carefully controlled patient populations and conditions of clinical trials.

The Study was conducted in collaboration with Dr Alex O’Beirne at the Western Orthopaedic Clinic; A/Prof Matthew Lawson-Smith at the Murdoch Orthopaedic Clinic; and Jaslyn Cullen at Innervate Occupational Therapy, and Hand Works Occupational Therapy.

Orthocell CEO and MD, Paul Anderson, said: We are delighted with the interim results from our Remplir RWE Study, validating the superior Remplir clinical outcomes, previously published in a highly regarded, peer reviewed journal. This performance is why more than 200 surgeons across more than 165 hospitals are now using Remplir and these numbers continue to grow.

This data is incredibly valuable from a commercial and regulatory perspective as it demonstrates the performance of Remplir across a heterogenous patient population in the real world, as distinct from a tightly controlled clinical trial environment.

It is imperative that we continue to collect performance data to drive the rapid market adoption in the US and support the EU & UK regulatory applications.

Remplir RWE Study Overview

The Remplir RWE study is an ongoing, multi-centre prospective and retrospective post-market clinical follow-up study being conducted in Australia (ACTRN12624001213538). The study is designed to collect safety and efficacy data on the use of Remplir in a real-world setting. Patients are eligible for inclusion in the study if they receive Remplir during any peripheral nerve procedure at a study site. Procedures ranged from complex nerve transfers and lower limb nerve repairs to more common surgeries used to treat carpal tunnel syndrome.  

The study population includes patients with acute traumatic nerve injuries (e.g. motor vehicle, work-related and sporting accidents), and chronic nerve injuries (e.g. carpal or cubital tunnel syndrome). Patients seek surgical treatment because their nerve injuries cause significant issues, such as muscle paralysis, pain, numbness, or burning/tingling sensations. The study collects data on outcomes related to the goals of surgical treatment (e.g. restoration of hand function after cervical spinal cord injury, relief of symptoms caused by carpal tunnel syndrome) for up to 24 months after treatment with Remplir.

Study Results

Data on 49 patients, aged 14 to 82 years, was included in the interim analysis. The patients underwent a total of 67 peripheral nerve procedures, most commonly in the upper limb (82%). The majority (61.2%) were nerve reconstruction procedures for acute injury (including nerve transfer and nerve grafting), and 38.8% were nerve decompression procedures using Remplir as a protective wrap in patients with chronic nerve injuries.  

Safety data was available for all 67 procedures, and no post-treatment complications or adverse reactions to Remplir were reported in any patient. Performance data was available for 43 procedures (53 therapeutic targets[3]). The overall treatment success rate for all procedure types was 81.1% (43 of 53 therapeutic targets). Results are summarised by the main procedure types below.

Significance of Study results and next steps

Considering these study results, published clinical data, and the rapid product adoption in existing markets, Orthocell believes Remplir has the potential to redefine the global nerve repair market and rapidly become the new gold standard in nerve repair surgery to return function to paralysed limbs and provide relief of symptoms. Interim study results will be presented at key medical conferences and the study continues in the recruitment phase.

Release authorised by:
Paul Anderson
Orthocell Ltd CEO and MD 

For more information, please contact:

 Media enquiries

 Haley Chartres

 H^CK Director

 P: +61 423 139 163

 E:  haley@hck.digital

About Orthocell Limited 
ACN 118 897 135
Registered Office – Building 191 Murdoch University, 90 South Street, Murdoch WA 6150 Australia.

For more information on Orthocell, please visit www.orthocell.com

[1] Company estimate of addressable market size for Remplir (AUS, NZ, SGP, USA, EU/UK, CAN, BRZ, JAP & THA). Sources include iData Research Inc and other publicly available market research reports and published literature. 

[2] USA nerve repair market size was estimated using referenced papers from both US and OUS databases and studies.

[3] Therapeutic target depends on procedure. Therapeutic target for motor nerve reconstruction is the muscle, and one reconstruction may innervate more than one muscle. Therapeutic target for nerve decompression is relief of symptoms.

Acer Reports Revenues for August at NT$21.80 Billion, and Year-to-August at NT$171.74 Billion

TAIPEI, Sept. 8, 2025 /PRNewswire/ — Acer Inc. (TWSE: 2353) announced its consolidated revenues for August at NT$21.80 billion, down 4.5% year-on-year (YoY) due to foreign exchange factors (up 2.2% YoY in USD). Year-to-August consolidated revenues reached NT$171.74 billion, remaining flattish (up 2.7% YoY in USD).

Highlights in August include:

  • Revenues from desktop PCs grew by 7.2% YoY
  • Revenues from gaming-related products and businesses grew 24.8% YoY

Acer’s strategy to expand multiple business engines continued to gain momentum. Total revenues from businesses other than personal computers[1] and displays contributed 33.3% of the group’s total revenues in August and 32.3% year-to-August.

Acer announced a host of new innovations at the next@acer global press conference in Berlin, including an ultra thin-and-light 16-inch laptop weighing less than 1kg, gaming PCs, and AI mini workstation built on the NVIDIA GB10 Superchip (Veriton GN100), in addition to its progress in Agentic AI and generative AI application for medical solutions.

[1] Personal computers business includes desktop and notebooks

About Acer

Founded in 1976, Acer is one of the world’s top technology companies with a presence in more than 160 countries. The company continues to evolve by embracing innovation across its offerings, which include computers and displays, while branching out to new businesses. Acer is also committed to sustainable growth, exploring new opportunities that align with its environmental and social responsibilities. The Acer Group employs over 9,000 employees that contribute to the research, design, marketing, sales and support of products, solutions, and services that break barriers between people and technology. Visit www.acer.com for more information.

© 2025 Acer Inc. All rights reserved. Acer and the Acer logo are registered trademarks of Acer Inc. Other trademarks, registered trademarks, and/or service marks, indicated or otherwise, are the property of their respective owners. All offers subject to change without notice or obligation and may not be available through all sales channels. Prices listed are manufacturer suggested retail prices and may vary by location. Applicable sales tax extra.